We are live on
!
Find out more
SIP
Stoneridge Investment Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
7.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.12%
1 Year Est. Return
+7.66%
3 Year Est. Return
+26.37%
5 Year Est. Return
+15.44%
10 Year Est. Return
+55.31%
AUM
$265M
AUM Growth
+$1.61M
(+0.61%)
Cap. Flow
-$4.39M
Cap. Flow
% of AUM
-1.66%
Top 10 Holdings %
Top 10 Hldgs %
37.8%
Holding
155
New
33
Increased
20
Reduced
44
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$4.52M |
| 2 |
CVS Health
CVS
|
+$4.51M |
| 3 |
L3Harris
LHX
|
+$4.09M |
| 4 |
Salesforce
CRM
|
+$3.6M |
| 5 |
Dollar Tree
DLTR
|
+$3.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.62M |
| 2 |
Visa
V
|
+$5.01M |
| 3 |
Humana
HUM
|
+$4.83M |
| 4 |
Digital Realty Trust
DLR
|
+$4.27M |
| 5 |
Rockwell Automation
ROK
|
+$4.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36% |
| 2 | Healthcare | 10.46% |
| 3 | Industrials | 9.79% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 9.38% |
Similar funds
DW
PF
AFW
RC
CPW
SMA
LDNAM
MFF
Stoneridge Investment Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Stoneridge Investment Partners held 155 positions worth $265M, up 0.61% from $263M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Stoneridge Investment Partners's Q2 2024 filing shows 33 new, 20 increased, 44 reduced and 28 closed positions. Its largest new stake was CVS Health: 72,169 shares worth $4.26M. The largest sale was Pfizer, an estimated $6.62M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Stoneridge Investment Partners's largest Q2 2024 buy was CVS Health: 72,169 shares worth $4.26M.
- Stoneridge Investment Partners added most to Bristol-Myers Squibb in Q2 2024, an estimated $4.52M increase.
- Stoneridge Investment Partners's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $2.39M.
- Stoneridge Investment Partners fully exited Pfizer in Q2 2024, selling an estimated $6.62M.
- Stoneridge Investment Partners's ten largest holdings make up 38% of its $265M portfolio in Q2 2024.
- Stoneridge Investment Partners opened 33 new positions and closed 28 in Q2 2024.
- Stoneridge Investment Partners's portfolio value rose 0.61% quarter-over-quarter to $265M.
Based on Stoneridge Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.